| PRIVILEDGE - AMERICAN CENTURY EMERGING MARKETS EQUITY (USD) N CAP | RVI EMERGENTES | 19,84% | 80,59% | 26,24% | · |
| BELLEVUE FUNDS (LUX) - BELLEVUE OBESITY SOLUTIONS I USD | RVI SALUD | 19,83% | 25,06% | -1,31% | 70,23% |
| BGF JAPAN SMALL & MIDCAP OPPORTUNITIES C2 USD | RVI JAPÓN SMALL/MID CAP | 19,83% | 62,65% | 28,50% | 72,93% |
| SANTANDER EUROPEAN DIVIDEND B CAP | RVI EUROPA VALOR | 19,83% | 48,80% | 52,36% | 75,33% |
| VONTOBEL FUND-MTX EMERGING MARKETS LEADERS A USD DIS | RVI EMERGENTES | 19,83% | 61,93% | 22,59% | 78,92% |
| WELLINGTON US RESEARCH EQUITY S USD A1 DIS | RVI USA | 19,83% | 78,85% | 66,30% | · |
| AMUNDI MSCI WORLD SRI CLIMATE PARIS ALIGNED RE CAP | RVI GLOBAL | 19,82% | 59,80% | · | · |
| BGF EMERGING MARKETS A2 USD | RVI EMERGENTES | 19,82% | 46,01% | 9,01% | 86,24% |
| CAPITAL GROUP EMERGING MARKETS EQUITY FUND (LUX) ZL EUR | RVI EMERGENTES | 19,82% | 61,00% | 23,71% | · |
| MIRAE ASSET ESG ASIA SECTOR LEADER EQUITY FUND A EUR CAP | RVI ASIA EX-JAPÓN | 19,82% | 63,81% | 28,10% | · |
